Acme United CorpACU
Price$63.42Intrinsic value$34.6345% below price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $34.63median of 5 methods · middle span $33-$37based on filings through 30 Jun 2026
Market Price $63.42Price as of 30 Sep 2026
Margin of Safety -45.4%as of 30 Sep 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: -15.0% (near-term consensus, capped) · years 2–5: -4.3%/yr (balance of the path).-6.6% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 6-2.9%Yr 7-1.4%Yr 80.1%Yr 91.5%Yr 103.0%
-4.3% → 3.0%
Years 11–20: glide to long-run rate
Per-year rates
Yr 113.0%Yr 123.0%Yr 133.0%Yr 143.0%Yr 153.0%Yr 163.0%Yr 173.0%Yr 183.0%Yr 193.0%Yr 203.0%
3.0% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 3 windows (5/6/7y)7.7%
Discount rate (cost of equity) 7.9%
Volatility vs market (adjusted beta)0.65

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetAcme United CorpACUHealth Care
Valuation
P/E26.6×
P/S1.1×
P/B2.1×
EV / Revenue1.2×
EV / EBITDA11.0×
Profitability
Gross margin39.7%
Operating margin3.3%
Net margin4.6%
FCF margin7.3%
Returns
ROE8.1%
ROA4.9%
ROIC7.1%
Growth
Revenue growth (YoY)8.8%
5-yr fwd EPS growth-6.6%
Financial strength
Debt / Equity0.19×
Current ratio3.23×
Altman Z-Score4.3
Interest coverage—
Dividend yield1.5%

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.